678
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Factors Influencing Medication Nonadherence to Pulmonary Tuberculosis Treatment in Tibet, China: A Qualitative Study from the Patient Perspective

ORCID Icon, , , , , & show all
Pages 1149-1158 | Published online: 10 Jul 2020

References

  • World Health Organization. Global Tuberculosis Report, 2019. Geneva: World Health Organization; 2019.
  • Li B, Zhang X, Guo J, et al. Prevalence of pulmonary tuberculosis in Tibet Autonomous Region, China, 2014. Int J Tuberc Lung Dis. 2019;23(6):735–740. doi:10.5588/ijtld.18.0614
  • Ministry of Health of the People’s Republic of China. National TB Control Program Implementation Guide in China. Beijing: Peking Union Medical College Press; 2008.
  • Maartens G, Wilkinson RJ. Tuberculosis. Lancet. 2007;370(9604):2030–2043. doi:10.1016/S0140-6736(07)61262-8
  • Hou W, Song F, Zhang N, et al. Implementation and community involvement in DOTS strategy: a systematic review of studies in China. Int J Tuberc Lung Dis. 2012;16(11):1433–1440. doi:10.5588/ijtld.12.0080
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
  • Wei X, Hicks JP, Pasang P, et al. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet. Trials. 2019;20(1):273. doi:10.1186/s13063-019-3364-x
  • Wolrd Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2005. Geneva: World Health Organization; 2005.
  • Okethwangu D, Birungi D, Biribawa C, et al. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017. BMC Infect Dis. 2019;19(1):387. doi:10.1186/s12879-019-4014-3
  • Woimo TT, Yimer WK, Bati T, Gesesew HA. The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study. BMC Public Health. 2017;17(1):269. doi:10.1186/s12889-017-4188-9
  • Yao S, Huang WH, van den Hof S, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011;11(1):341. doi:10.1186/1472-6963-11-341
  • Chen S, Zhang H, Pan Y, et al. Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Infect Dis Poverty. 2015;4(1):47. doi:10.1186/s40249-015-0080-y
  • Lei X, Huang K, Liu Q, Jie YF, Tang SL. Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study. Infect Dis Poverty. 2016;5(1):38. doi:10.1186/s40249-016-0134-9
  • Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9(1):169. doi:10.1186/1472-6963-9-169
  • Tang Y, Zhao M, Wang Y, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15(1):474. doi:10.1186/s12889-015-1789-z
  • Xu M, Markstrom U, Lyu J, Xu L. Detection of low adherence in rural tuberculosis patients in China: application of morisky medication adherence scale. Int J Environ Res Public Health. 2017;14(3):E248. doi:10.3390/ijerph14030248
  • Azizi N, Karimy M, Salahshour VN. Determinants of adherence to tuberculosis treatment in Iranian patients: application of health belief model. J Infect Dev Ctries. 2018;12(9):706–711. doi:10.3855/jidc.9653
  • Zegeye A, Dessie G, Wagnew F, et al. Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis. PLoS One. 2019;14(1):e0210422. doi:10.1371/journal.pone.0210422
  • Nellums LB, Rustage K, Hargreaves S, Friedland JS. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis. BMC Med. 2018;16(1):27. doi:10.1186/s12916-017-1001-7
  • Diefenbach-Elstob T, Plummer D, Dowi R, et al. The social determinants of tuberculosis treatment adherence in a remote region of Papua New Guinea. BMC Public Health. 2017;17(1):70. doi:10.1186/s12889-016-3935-7
  • Gebreweld FH, Kifle MM, Gebremicheal FE, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):1. doi:10.1186/s41043-017-0132-y
  • Sahile Z, Yared A, Kaba M. Patients’ experiences and perceptions on associates of TB treatment adherence: a qualitative study on DOTS service in public health centers in Addis Ababa, Ethiopia. BMC Public Health. 2018;18(1):462. doi:10.1186/s12889-018-5404-y
  • Schulman-Green D, Jaser SS, Park C, Whittemore R. A metasynthesis of factors affecting self-management of chronic illness. J Adv Nurs. 2016;72(7):1469–1489. doi:10.1111/jan.12902
  • Skinner D, Claassens M. It’s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infect Dis. 2016;16(1):712. doi:10.1186/s12879-016-2054-5
  • Tadesse T, Demissie M, Berhane Y, Kebede Y, Abebe M. Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study. BMC Public Health. 2013;13(1):424. doi:10.1186/1471-2458-13-424
  • World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014.
  • Story A, Aldridge RW, Smith CM, et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet. 2019;393(10177):1216–1224. doi:10.1016/S0140-6736(18)32993-3
  • Browne SH, Umlauf A, Tucker AJ, et al. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: a randomized controlled trial. PLoS Med. 2019;16(10):e1002891. doi:10.1371/journal.pmed.1002891
  • Bediang G, Stoll B, Elia N, Abena JL, Geissbuhler A. SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial. BMC Public Health. 2018;18(1):583. doi:10.1186/s12889-018-5502-x
  • Liu X, Lewis JJ, Zhang H, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9):e1001876. doi:10.1371/journal.pmed.1001876
  • Gugssa Boru C, Shimels T, Bilal AI. Factors contributing to non-adherence with treatment among TB patients in Sodo Woreda, Gurage Zone, Southern Ethiopia: a qualitative study. J Infect Public Health. 2017;10(5):527–533. doi:10.1016/j.jiph.2016.11.018
  • Wang W, Shi L, Yin A, et al. Primary care quality between traditional Tibetan medicine and western medicine hospitals: a pilot assessment in Tibet. Int J Equity Health. 2015;14(1):45. doi:10.1186/s12939-015-0174-y
  • Da Silva RD, De Luna FDT, De Araujo AJ, et al. Patients’ perception regarding the influence of individual and social vulnerabilities on the adherence to tuberculosis treatment: a qualitative study. BMC Public Health. 2017;17(1):725. doi:10.1186/s12889-017-4752-3
  • Fang XH, Dan YL, Liu J, et al. Factors influencing completion of treatment among pulmonary tuberculosis patients. Patient Prefer Adherence. 2019;13:491–496. doi:10.2147/PPA.S198007
  • Tesfahuneygn G, Medhin G, Legesse M. Adherence to anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes. 2015;8(1):503. doi:10.1186/s13104-015-1452-x
  • Gideon K. Factors Influencing Clients Adherence to Tuberculosis Treatment in Birim South. School of Public Health, University of Ghan; 2019.